Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica.

Literature DB >> 843118

Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica.

Abstract

A 70-year-old woman presenting with typical polymyalgia rheumatica (PMR) and a normal temporal artery biopsy appeared to respond completely to low-dose prednisone therapy. A subsequent biopsy showing temporal arteritis with a normal sedimentation rate and no recurrence of myalgic symptoms emphasizes the unpredictable course of treated PMR and the need for continued clinical as well as laboratory follow-up.

Entities: Chemical Disease Species

Mesh：

Substances：
Prednisone

Year: 1977 PMID： 843118 PMCID： PMC1006638 DOI： 10.1136/ard.36.1.88

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

8 in total

1. Granulomatous arteritis with myocardial infarction: a case report with autopsy findings.

Authors: A N MORRISON; M ABITBOL
Journal: Ann Intern Med Date: 1955-03 Impact factor: 25.391

2. Polymyalgia rheumatica.

Authors: G G Hunder; T F Disney; L E Ward
Journal: Mayo Clin Proc Date: 1969-12 Impact factor: 7.616

3. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings.

Authors: P Fauchald; O Rygvold; B Oystese
Journal: Ann Intern Med Date: 1972-12 Impact factor: 25.391

Review 4. Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica.

Authors: C R Hamilton; W M Shelley; P A Tumulty
Journal: Medicine (Baltimore) Date: 1971-01 Impact factor: 1.889

5. Polymyalgia rheumatica and its relation to arteritis temporalis.

Authors: O A Kogstad
Journal: Acta Med Scand Date: 1965-11

6. Giant cell arteritis--the need for prolonged treatment.

Authors: D G Beevers; J E Harpur; K A Turk
Journal: J Chronic Dis Date: 1973-09

7. Articular and vascular manifestations of polymyalgia rheumatica.

Authors: M I Bruk
Journal: Ann Rheum Dis Date: 1967-03 Impact factor: 19.103

8. Large artery involvement in giant cell (temporal) arteritis.

Authors: R G Klein; G G Hunder; A W Stanson; S G Sheps
Journal: Ann Intern Med Date: 1975-12 Impact factor: 25.391

8 in total

11 in total

Review 1. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors: Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal: Drugs Aging Date: 2006 Impact factor: 3.923

2. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.

Authors: V Kyle; T E Cawston; B L Hazleman
Journal: Ann Rheum Dis Date: 1989-08 Impact factor: 19.103

Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica.

1. Granulomatous arteritis with myocardial infarction: a case report with autopsy findings.

2. Polymyalgia rheumatica.

3. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings.

Review 4. Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica.

5. Polymyalgia rheumatica and its relation to arteritis temporalis.

6. Giant cell arteritis--the need for prolonged treatment.

7. Articular and vascular manifestations of polymyalgia rheumatica.

8. Large artery involvement in giant cell (temporal) arteritis.

Review 1. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

2. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.

3. Giant cell arteritis precipitated by a diagnostic trial of prednisolone in suspected polymyalgia rheumatica.

4. Polymyalgia arteritica.

Review 5. Inflammatory conditions of the eye associated with rheumatic diseases.

6. Granulomatous lipophagic panniculitis and temporal arteritis in a patient with cryptogenic chronic active hepatitis.

7. Polymyalgia rheumatica. Assessment of disease activity using erythrocyte sedimentation rate and plasma viscosity.

8. Polymyalgia rheumatica: a general practice experience.

9. Hepatocellular disease in the giant-cell arteritis/polymyalgia rheumatica syndrome.

10. Prognosis and management of polymyalgia rheumatica.